Lam Ching Wan's Form 4 filing
Green Vision Biotechnology Corp. · filed Feb 10, 2022
- Accession no.
- 0001707195-22-000002
- Filed
- Feb 10, 2022
- Trade date
- Jan 17, 2022
- Filing delay
- 24 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. It was filed 24 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lam Ching WanCIK 0001707195 | Director, Officer (CHIEF EXECUTIVE OFFICER), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 17, 2022 | Common Stock | PPurchaseAcquired | +75,674,200 | $0.00 | $0 | 75,674,200 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.